Meditation is not a word for
“Dhayana”. Meditation is a relationship of Subject and Object where one is
practicing or contemplating something…but subject remains always there. But in
Indian consciousness (again “Chetna” or “Minisha” are better) “Dhayana” is a
state where subject dissolve into Unknown…subject just vanishes…it becomes one
with whole or we can better say it realizes the illusion of separateness…fragmentation
is a state of Mind while oneness is the reality…when one experience this…it is
Dhayana…it is not a process but a state. And because there is no subject; so
every Dhayani (Say Meditator) faces the problem of explaining his experience in
our worldly language and when they try they appear out of Subject and Lunatic.
It is just like trying to make a child understand the meaning of love…not
understanding is not the issue but the child can relate his love for Chocolate
with our love for our better half. The whole chaos we are seeing for ages is
because children are trying to understand Love from their “State” and some says
Love is Chocolate, for some it is Toys and for some it is ice cream.
Stock analysis is also just like
Meditation…very deep, enjoyable and engaging but as subject remains (unmelt) so
he can explain it. Business is even deeper meditation…contemplating the
Unknown…dragging the future into present…business contemplates the oneness of
worldly forces better than our religions and tries to gasp the future trend.
But biggest risk factor is not the subject-matter but only the Subject….the
businessman. I call it the Management Risk. I take management risk as the
biggest threat to a business venture. External factors are always isolated and
beyond control but business is never about controlling them but being in the
harmony of these. Harmony is about the meditators. So there can be chances when
external factors are out of favor but a true meditator will eventually resonate
with these.
So capability of management is the
biggest factor in the success or failure of a business. All the measurement
variables of success like cash, market share, profitability etc. are just derivatives
of the management. When I bought stocks like NIIT, jain irrigation in their
tough times….it was just because of the management which is top class. Then, if
external factors are affecting any business too frequently like in commodity
business like Steel where too many external factors become alive time and again….like
global over supply, low global demand…these can kill anyone without any of
their fault…I call it Frequency Risk. So I generally avoid these types of
companies.
So in today’s post, I am going to
share some companies which are meditating quietly for a long time. So no
wonder, they remain unnoticed. But the scale of success is enormous and if they
succeed they will be giants. Another thing about these stocks is that almost
all have already been shared with the readers of this blog who have subscribed
to the email of this blog. Actually the reason for not sharing at this blog was
because I was still to complete the final analysis and sometimes the lack of
time. However I am feeling somewhat down as some of these stocks have already
run up quite a bit. But the good thing is that most of email subscribers are
having it so they might find this post just a copy of my emails. But today I am
just posting basic introductions to these stocks due to lack of time and length
of the post .
JM Financial and
Edelweiss: Two
of the best NBFC’s available at cheap rates. With great return over equity but
still available at PE ratios of 10. JM Financial’s ROE is around 25%, Dividend
yield is 3-4% but still running at a pe ratio of just 8! Both are having some
Niche businesses like JM is the biggest indian in Investment Banking business
which is a fee based business so margins are very high. Edelweiss is very
strong in Equity broking and Insurance. Edelweiss is going to be one of the biggest
beneficiaries of growth in equity broking business as more indians will come to
the market due to high cost of real estate and sluggishness in Gold. Indians
invest just 1% in equity, chinese at 15-20%...USA may be around 30% or so...so
just see the scale.
But the surprise package will be their
ARC (Assets reconstruction companies) business. Indian banks are estimated to
have NPA’s of around 3 lac crore. Mr. Raghuram is focusing on cleaning the mess
in the books of banks so banks are selling these NPA’s to ARC’s like never
before. Both Edelweiss and JM are already the biggest players in this.
Edelweiss bought around 20000 cr of NPA in recent times (it bought the NPA of
Arshiya international while JM is curing Hotel Leela). I think that ARC’s are a
good remedy to the businesses facing the systematic risks and can be saved by
these ARC’s as they can provide these businesses with working capital and with
their expertise they can enable them pass the difficult time. Like Arshiya
expanded into FTWZ business too fast too soon but it was a novel business idea
and can be saved. But there is no remedy for bad business decision and fraud
and in those situations only remedy is to dispose of the assets and save as
much as you can.
JM is at 45 and Edelweiss at 68. Both
have already run up quite a bit especially Edelweiss from 50 to 70 but still long
way to go.
Zydus wellness: This is one stock where scale of operation is
too big to ignore. It is into the wellness sector offering unique products like
zero calorie sugar derivatives (Sugar Free Brand, with 93% market share),
Nutralite brand providing low chelostrol substitute for butter, Everyuth brand
in peel and scrub category with biggest market share. it is at a pe ratio of 33
and almost doubled...but this is nothing...peanut. Its main product Sugar free
is having 90% market share and it is essential for diabetic patients. i am
ignoring other health conscious persons using it. Its sugar free turnover is
just 300 cr.
Now we do some calculations...india has 7 cr diabetics. Now take
that in future only 3 cr will use sugar free. They will use 3-4 sugar drops per
day, i am taking 4. Zydus charges around 60/- for 100 drops of sugar free and
it has not raised the prices for last 3-4 years. Also its sugar free Natura and
Herbivia are natural products and should command 50% more prices, i am ignoring
this also. So taking 4 drops, the yearly possible turnover is 2600 cr...that
too at old prices!!!. You can add health conscious person using the same and
add price raises plus costly Natura and Herbivia and raise the usage to 6-8
drops.....it will become almost 5000 cr...add
to it export growth...it will rise further. it is a concept stock and risk
reward ratio is highly favorable. Sugar free now is generic name...but still
people take it as chemical sugar when in fact some of its brands are natural
sugars...so it just need to up the ante for Branding.
It is planning big for herbal zero
calorie sugar Stevia...it has been finally approved by FSSAI around Nov-15...so
now cola companies can use it and directions can be issued for its use.
Zydus has again started branding and
awareness drive for its natural sugars like Natura which are not chemicals like
earlier Sugar Free Gold. So once people understand this the demand will be
huge. It has ignored Everyuth in the past although it is a great product, so
due to no sales promotion people forget it. But now it is back on the TV and
company is focusing on growing it again.
For Margarine (Butter substitute)
Nutralite; it doesn’t taste that good like butter. So I think it would be great
if Zydus focus more on enhancing the taste or it can add some percentage of
butter to enhance the taste.
It was showing flat results for many
quarters, but finally in Mar-16 quarter it has shown good growth...turnover 109 cr vs
97 cr...operating profit at 22 cr from
12 cr, NP at 25 cr vs 20 cr due to other income and taxation effect. I think it
has raised the price of its products which was due for long. At CMP of around 770…it is a great buy.
Dr. Agarwal’s Eye
Hospital: I picked it up when it was around 70 few years back. It
is one of the biggest Eye care chain in india with 60 hospitals with around 44
in India and 16 abroad.
This
hospital was promoted by late Dr. J agarwal who came to Mumbai around 1955 with
just Rs. 250/- in his pocket with his wife and from a very humble beginning
from small clinic with borrowed money for essential tools his vision and
passion has created a eye care behemoth with annual turnover of around 100 cr
and number of hospitals under its domain has increased to around 60 in all over
india.
His
son Dr amar agarwal MS, FRCS, FRCOphth, who is a stalwart in the field of Eye
care and invented some new eye treatment techniques (like
Performing pain-free, no-anesthesia cataract surgery) and written many
books in the field of eye care is now leading the team towards a global growth
path. They are a good management team doing almost 1000 eye operation in a year
free of cost for poor people.
Its
turnover is around 130 cr with negligible profits this year which may surprise
many as eye care is a very profitable business. However this is due to rising
competition where some eye care chains expanded too much in overcrowded
southern market where Dr Agarwal has significant presence. The main culprit was
Vasan Eye care who on its disastrous expansion spree expanded to almost 200 eye
hospitals in around 3-4 years…but its growth (Weight) was fuelled by Debt (Fat)
not equity (Muscles). So when it could no longer bear its weight, it just
collapsed and its private equity partners like GIC and Sequoia took big losses.
Players like Vasan brought down the prices of eye care. That’s why Dr agarwal
sees its operating margins falling in last 1-2 years.
But
it has big plans for investing around 600 cr for expansion. It is too strong in
R&D and cutting edge technology in fact Vasan established its first
hospital with the technological assistance from Dr Agarwal. Recent equity
investments in Dr Agarwal is valuing it around 500 cr while its Current market
value is just under 100 cr. CMP is 150. I am adding more at CMP.
Piramal Enterprises: This is my all-time
favorite and invested in it at 500, then at 800 and 950. But I couldn’t post my
study as it was expanding too fast and new businesses required deep study like
its investment in pharma Information management company Decision Resource PLC
in USA. It is into NBFC, Pharma, Information management. I just kept on adding
it only on the basis of one man…and that is Mr. Ajay Piramal…the promoter of
the group. I see him as one of the best value investor in india. It is now around 1350…a big rise but there is no doubt that it is just the beginning. It will
become bigger and bigger. There are so many catalysts pending like demerger of
its various businesses, Merger with Shriram group, Merger with IL&FS group
etc. so it still can be picked at CMP and at every fall.
Forbes Gokak: Already posted a
study about it when it was around 500 click here. But it is still unknown to many. It is
the owner of Eureka forbes, the biggest water and home equipment company in
india with unmatched R&D skills. It manufactures its product on its own and
been the pioneer in bringing many new water treatment technologies. Turnover of
Eureka Forbes alone is around 1800 cr with NP of 40-50 cr….while market valuation
is just 1700 cr so it is at PE ratio of just 35-40 which is cheap…although we
have not priced its other businesses like tools and payment solutions etc. I
have invested quite early in it around 500, then at 700 and now at 1300. It is
still a good buy at CMP of 1300/-.
Narayana Healthcare: Dr Devi Shetty is
revolutionizing the healthcare industry with unimaginable low cost healthcare
model. Earlier they were more like Good Company with the main objective of
serving the poor. But you can’t grow with non-profit model. So they were having
different models for rich and poor but with same high quality services. But
they need more profit to grow bigger and provide cheaper services to all.
Earlier actually
i was a bit apprehensive whether Narayana would be able to show the kind of
growth to justify the high valuation. And it just did the same in Dec-15 qtr
result with its operating profit rising almost 5 times from 5 cr to 25
cr...also finance cost fell to 3 cr from 11 cr.
As
it is following wholesale type of business model; so any incremental revenue
will add significantly to the bottom. Also as it is now listed so it will also
focus on more profits as compared to earlier past.
I am a big fan of Dr Devi shetty so
i am a bit biased for it due to this. I also have a great respect for Dr.
Venkatawamy (Dr V as he is called) of Arvind Eye care...these men are just
awesome. I have read somewhere that doctors of Aravind Eye care perform around
2000 eye surgeries as compared to 400 global avg and 200 asian avg!!!
But players like NH are
the next big opportunity for india to shine at global scale and bring in the
huge foreign exchange even bigger than IT industry. NH is providing even better
services than its global counterparts in USA at fraction of their costs. So huge
number of people will visit india for cheaper and quality treatment in the near
future. NH market value is just 6000 (No need to compare it with their revenue,
just compare with the future scale) with turnover of around 1200 cr. This will
grow much bigger from here. A great buy at 310 and at every fall.
BASF and Clariant
Chemicals: Global Chemicals giants with great R&D and technologies.
Some of the very few MNC’s who have invested big in india. They were incurring
losses as it takes time for new capacities to churn profits as big depreciation
in the beginning also squeeze the margins. Chinese cheap chemicals were also
the factor but these are old horses. BASF and Clariant has already shown huge
improvements in this Mar-16 quarter. BASF is at 950 and Clariant is at 690.
(Views
are personal and should not be taken as a recommendation for buying or
selling a stock. Stock markets are inherently risky so kindly do your
Due Diligence before investing. I am not a certified Sebi Analyst and holding the shares discussed in this Post)